Hebrew University
Jerusalem, Israel
Location status: Recruiting
Location contact
Adina Maeir, PhD
CONTACT
Adina Maeir, PhD
CONTACT
Ruthie Traub Bar Ilan, PhD
CONTACT
NCT Number: NCT06639139
The goal of this clinical trial is to examine the effectiveness of Cognitive-Functional Remote Group intervention (Cog-Fun RG).
The main questions of this study are 1. will participants demonstrate improvements in their executive functioning and quality of life after receiving the intervention, compared to waitlist controls. In addition, the investigators will examine if the waitlist group will demonstrate similar gains in these outcomes after receiving the same intervention.
the investigators will compare between the intervention group to the waiting list group to examine the effect of the intervention.
The participants will be allocated into two groups: an intervention group and a waiting list group.
The intervention group will receive the the Cog-Fun RG intervention, which includes 21 weekly group sessions, each lasting 90 minutes. the participants will be required to complete questionnaires at several time points: pre-post the intervention, as well as three months, six months, and one year after the intervention.
The waiting list controls will be required to complete questionnaires at several time points: pre-post waiting period, and then after the intervention, as well as three months, six months, and one year after the intervention.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Jerusalem, Israel
Location status: Recruiting
Adina Maeir, PhD
CONTACT
Adina Maeir, PhD
CONTACT
Ruthie Traub Bar Ilan, PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
21 weekly, online group sessions (4-6 participants in each group), lasting 90 minutes. Sessions are structured, comprising opening, collaborative learning, and summary. Session topics include learning about ADHD as a biological disorder of executive functioning, understanding the impact of ADHD on daily life, discovering strategies for coping with ADHD through exploration of life experiences, and preparing for future self management
Time frame: at baseline, immediately after the intervention, immediately after the waiting period and 3 months after the intervention follow up
Questionnaire with 29 questions relating to productivity, life outlook, relationships and psychological health. each question is rated on a 5 point scale. Raw scores are transformed to a 1-100 scale. higher scores indicate higher quality of life. The assessment will be conducted at baseline, immediately after the intervention, immediately after the waiting period and 3 months after the intervention follow up.
Time frame: at baseline, immediately after the intervention, immediately after the waiting period.
Self-report questionnaire for adults evaluates Executive Functions (EF) in everyday contexts. Comprising 75 items rated on a three-point scale (1 = never, 2 = occasionally, 3 = often), the questionnaire categorizes items into nine scales representing distinct EF domains, along with two primary indices. The first, the Behavioral Regulation Index (BRI), encompasses inhibition, shifting, emotional regulation, and behavioral monitoring. The second, the Metacognitive Index (MI), includes working memory, initiation, planning/organization, task monitoring, and organization of materials. These indices contribute to a composite summary score known as the Global Executive Composite (GEC). raw scores are transposed to T-scores based on norms. The assessment will be conducted pre-post the intervention. Higher scores indicating greater difficulty with EF; a score of 65 or above signifies clinical impairment.
Contact information is provided by the study sponsor or research team.
Adina Prof. Maeir, PhD
CONTACT
Ruthi Dr Traub Bar Ilan, PhD
CONTACT
Hebrew University of Jerusalem
Other
Acronym: ADHD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT07717879
ADHD, Attention Deficit Disorder with Hyperactivity
Dothan, Alabama, United States
View Trial DetailsNCT07717892
ADHD, Attention Deficit Disorder with Hyperactivity
Dothan, Alabama, United States
View Trial DetailsNCT06284655
ADHD, Attention Deficit Disorder with Hyperactivity
Trondheim, Norway
View Trial Details